Clinical Trial Update: Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating combined dehydropeiandrosterone and growth hormone in women with expected poor ovarian response undergoing ICSI for subferti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subfertility

Drugs mentioned

• Growth Hormone (somatropin)
• dehydropeiandrosterone (dehydropeiandrosterone)

Snippet

Sponsor: Cairo University | Conditions: Subfertility | Phase 4 | Status: UNKNOWN